Skip to main content
Hester Biosciences Ltd logo

Hester Biosciences Ltd — Investor Relations & Filings

Ticker · HESTERBIO ISIN · INE782E01017 LEI · 984500836B9EB1DC4935 BSE.NS Manufacturing
Open in API
Filings indexed 672 across all filing types
Latest filing 2026-05-20 Capital/Financing Update
Country IN India
Listing BSE.NS HESTERBIO

About Hester Biosciences Ltd

https://www.hester.in/

Hester Biosciences Ltd specializes in the development, manufacturing, and marketing of animal healthcare products. The company primarily focuses on two segments: poultry healthcare and livestock healthcare. Its extensive product portfolio includes a wide range of live and inactivated vaccines, as well as health products such as therapeutics, herbal supplements, and disinfectants. Hester is recognized for its significant contributions to global animal disease control programs, particularly in the eradication of Peste des Petits Ruminants (PPR) and Brucellosis. The company operates advanced manufacturing facilities and maintains a robust distribution network to serve domestic and international markets. By leveraging research and development, Hester provides diagnostic services and technical support to enhance animal productivity and welfare. Its commitment to quality and innovation has established it as a key provider of biologicals and health solutions for the veterinary sector.

Recent filings

Filing Released Lang Actions
General Updates
Capital/Financing Update Classification · 85% confidence The document is a formal disclosure under SEBI Listing Regulations describing amendments to an existing loan agreement (loan facility reduction, interest terms, repayment schedule) and the continuing corporate guarantee by the listed entity—this is a financing update regarding debt arrangements rather than a full financial report or other notice. Therefore, it falls under Capital/Financing Update (CAP).
2026-05-20 English
Announcement under Regulation 30 of Listing Regulation - Amendments in Loan agreement of Hester Africa
Capital/Financing Update Classification · 90% confidence The document is a formal letter to stock exchanges under SEBI Listing Obligations Regulation 30 disclosing amendments to an existing loan agreement (a financing activity). It details revised loan amounts, interest waivers, tenor extension, and repayment schedule changes. This is not an earnings release or a full report, but a material update on the company’s financing arrangements. Therefore, it falls under Capital/Financing Update (CAP).
2026-05-20 English
General Updates
Regulatory Filings Classification · 67% confidence The document is an intimation letter to Indian stock exchanges regarding an application for reclassification of shareholders under SEBI Listing Regulations. It contains no financial statements or report, but is a compliance filing notifying a corporate action (shareholder category reclassification). This fits best into the general regulatory filings category as a miscellaneous compliance announcement rather than a specific report or financial disclosure.
2026-05-20 English
Intimation of Submission of reclassification application with the stock exchanges under Regulations 31A of Listing Regulations
Regulatory Filings Classification · 85% confidence The document is an intimation letter to stock exchanges regarding submission of an application for re-classification of certain shareholders under SEBI Listing Regulations. It is a compliance/regulatory announcement rather than a financial report, management discussion, dividend notice, share issue, or director dealing disclosure. It therefore best fits the generic “Regulatory Filings” category as a miscellaneous compliance announcement.
2026-05-20 English
Annual Secretarial Compliance Report for the year ended 31 March 2026
Regulatory Filings Classification · 90% confidence The document is an Annual Secretarial Compliance Report issued by a Practicing Company Secretary pursuant to SEBI Listing Regulations. It is a compliance certification letter (attestation) rather than a full financial report (annual, interim, etc.) or specific transaction announcement. Under the “Certification Rule,” officer certifications or attestation letters fall into the generic Regulatory Filings category. Therefore, this is classified as RNS.
2026-05-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document contains the full transcript of the company’s Q4 & FY26 earnings conference call, including moderator introductions, management remarks, and detailed Q&A. This fits the definition of a Call Transcript (CT).
2026-05-18 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.